Share
The London School of Economics and Political Science public events podcast series is a platform for thought, ideas and lively debate where you can hear from some of the world's leading thinkers. Listen to more than 200 new episodes every year.
…
continue reading
Manage episode 482799466 series 3313712
Content provided by The Vet Blast Podcast. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Vet Blast Podcast or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Christopher Pinard, DVM, DVSc, DACVIM (Oncology), is a clinician scientist and medical oncologist at Lakeshore Animal Health Partners, adjunct professor at the University of Guelph, and CEO of ANI.ML Health Inc. ANI.ML Health integrates AI and spatial computing to enhance veterinary care, launching Hachiko in 2025—a first-of-its-kind veterinary medical record summarizer.
His research focuses on AI-driven biomarkers for canine and feline cancers, leveraging machine learning for comparative oncology. He explores spatial computing, 3D modelling, and AI to improve patient outcomes.
Pinard has co-authored multiple AI-focused publications and is a faculty affiliate at CARE-AI. He is also a member of T-CAIREM and the International Immuno-Oncology Biomarker Working Group. He has served on the Morris Animal Foundation Osteosarcoma Scientific Advisory Board and ACVIM’s AI Task Force. He is currently the guest editor of BMC Veterinary Oncology’s special issue on AI and Informatics. His research is actively funded for next-generation AI in medicine.
His research focuses on AI-driven biomarkers for canine and feline cancers, leveraging machine learning for comparative oncology. He explores spatial computing, 3D modelling, and AI to improve patient outcomes.
Pinard has co-authored multiple AI-focused publications and is a faculty affiliate at CARE-AI. He is also a member of T-CAIREM and the International Immuno-Oncology Biomarker Working Group. He has served on the Morris Animal Foundation Osteosarcoma Scientific Advisory Board and ACVIM’s AI Task Force. He is currently the guest editor of BMC Veterinary Oncology’s special issue on AI and Informatics. His research is actively funded for next-generation AI in medicine.
339 episodes
))
